| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,857,057 | 3,526,162 | 2,707,368 | 2,434,308 | 2,204,302 |
| Cost of Revenue
|
-3,297,410 | -2,966,719 | -2,191,427 | -1,946,901 | -1,823,719 |
|
Gross Profit
|
559,647 | 559,443 | 515,941 | 487,407 | 380,584 |
| Selling, General and Administrative Expenses
|
-547,024 | -548,531 | -1,265,238 | -515,247 | -441,750 |
|
Research and Development Expenses
|
-- | -- | -- | -41,532 | -61,783 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | -4,385 | -4,198 |
| Other Income/Expense, Operating
|
615 | 615 | 415 | 1,026 | 526 |
|
Operating Income/Expenses
|
-546,409 | -547,916 | -1,264,823 | -514,221 | -507,205 |
|
Total Operating Profit/Loss
|
13,238 | 11,527 | -748,882 | -26,814 | -126,621 |
| Total Net Finance Income/Expense
|
-1,154 | -1,396 | -77,160 | -144,816 | -121,781 |
| Net Investment Income
|
-10,816 | 903 | -33,603 | -28,444 | -134,660 |
| Irregular Income/Expenses
|
-1,280 | -1,698 | -334 | -140 | -173 |
|
Other Income/Expense, Non-Operating
|
3,923 | 2,690 | 5,126 | 3,503 | -54 |
|
Non-Operating Income/Expenses, Total
|
-9,327 | 499 | -105,971 | -169,897 | -256,668 |
|
Pretax Income
|
3,911 | 12,026 | -854,853 | -196,711 | -383,289 |
|
Provision for Income Tax
|
4,344 | -194 | -32 | -77 | -13 |
|
Net Income from Continuing Operations
|
8,255 | 11,832 | -854,885 | -196,788 | -383,302 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
8,255 | 11,832 | -854,885 | -196,788 | -383,302 |
|
Non-Controlling/Minority Interests
|
-- | -- | -- | 0 | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
8,255 | 11,832 | -854,885 | -196,788 | -383,302 |
|
Net Income Available to Common Stockholders
|
8,255 | 11,832 | -854,885 | -196,788 | -383,302 |
|
Diluted Net Income Available to Common Stockholders
|
8,255 | 11,832 | -854,885 | -196,788 | -383,302 |
| Basic EPS
|
0.01 | 0.01 | -0.88 | -0.15 | -0.29 |
| Diluted EPS
|
0.01 | 0.01 | -0.88 | -0.15 | -0.29 |
|
Basic Weighted Average Shares Outstanding
|
1,354,082.718 | 1,332,982 | 975,922 | 1,340,267.457 | 1,340,267.457 |
|
Diluted Weighted Average Shares Outstanding
|
1,364,160.053 | 1,345,569 | 975,922 | 1,340,267.457 | 1,340,267.457 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
5,065 | 13,422 | -852,616 | -195,071 | -382,122 |
|
EBITDA
|
5,065 | 34,503 | -828,500 | -174,756 | -364,686 |
|
Normalized EBITDA
|
12,340 | 45,489 | -51,246 | -140,960 | -216,191 |
12/31/2022 - 7/9/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade